← Open Payments lookup

VERLANDE DORILAS: Open Payments

NPI 1396526497 · RENO, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$776 in 37 payments from 12 companies in 2025. Trend: 2023 $15 · 2024 $44 · 2025 $776

Food & beverage: $776
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.11$225
Vanda Pharmaceuticals Inc.4$119
Janssen Pharmaceuticals, Inc2$60
ABBVIE INC.3$59
Neurocrine BioSciences, Inc.3$59
Alkermes, Inc.2$58
Sage Therapeutics, LLC3$46
Axsome Therapeutics, Inc.2$37
Teva Pharmaceuticals USA, Inc.2$33
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$31

Products named: REXULTI, FANAPT, ABILIFY ASIMTUFII, SPRAVATO, INGREZZA, ARISTADA, ZURZUVAE, VRAYLAR.

Industry payments across NV — which companies pay providers there.